AORT
AORT clinical trials: ARTIVION, INC.
Every trial on ClinicalTrials.gov where ARTIVION, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 27
- Trials linked
- 19
- As lead sponsor
- 8
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
AORT on the catalyst calendar · AORT registry changes
- Primary completion Apr 2028Sponsor estimateNo phase registeredNCT07089576Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSAArtivion Inc. · Aortic Arch AneurysmRecruitingAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2034Sponsor estimateNo phase registeredNCT07413926Mitral Valve Repair With the Chord-X System: A Long Term EvaluationArtivion Inc. · Mitral Regurgitation (MR)Not yet recruitingAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 11, 2023ActualNo phase registeredNCT05174767PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I DissectionArtivion Inc. · Acute Aortic DissectionActive, not recruitingAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 10, 2020ActualNo phase registeredNCT03669042Post-market, Prospective Evaluation of PHOTO-oxidized Bovine Pericardium in Vascular SurgeryArtivion Inc. · Vascular DiseasesCompletedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2016ActualNo phase registeredNCT01799811Cryopreserved Saphenous Vein Allograft in Patients With Critical Limb Ischemia for Peripheral RevascularizationCryoLife, Inc. · Critical Limb IschemiaCompletedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 12, 2022ActualPhase 3NCT04142658PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on ApixabanArtivion Inc. · Aortic Valve DiseaseTerminatedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 30, 2022ActualNo phase registeredNCT05314868Retrospective Evaluation of Photo-oxidized Decellularized Bovine Pericardium in Cardiac Repair or Reconstruction SurgeryArtivion Inc. · Congenital Heart DiseaseTerminatedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 11, 2019ActualNo phase registeredNCT02359994Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot®...Artivion Inc. · Blood Loss, SurgicalCompletedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 1, 2020ActualNo phase registeredNCT03347851Post-surgical Aortic Hemodynamics After Aortic Valve ReplacementCryoLife, Inc. · Valve Heart DiseaseCompletedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2020ActualNo phase registeredNCT02694861CardioGenesis Transmyocardial Revascularization 1-Year Follow-Up StudyCryoLife, Inc. · Class IV AnginaCompletedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 24, 2018ActualNo phase registeredNCT03369977BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections PatientsCryoLife, Inc. · Type A Aortic DissectionActive, not recruitingAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2018ActualNo phase registeredNCT03307499NeoPatch Used as Adjunct in Foot and Ankle Tendon SurgeryCryoLife, Inc. · TendinopathyCompletedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2014ActualNo phase registeredNCT01845103The PEARL 8.0 Post-Approval StudyCardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. · Class IV AnginaTerminatedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2014ActualNo phase registeredNCT01092442CryoValve SG Pulmonary Human Heart Valve Post Clearance StudyCryoLife, Inc. · Pulmonary Valve StenosisCompletedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2015ActualNo phase registeredNCT01827319Cardiogenesis Transmyocardial Revascularization RegistryCardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. · Class IV AnginaCompletedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2012ActualNo phase registeredNCT01285297Safety Study of Transmyocardial Revascularization (TMR) With Bone Marrow Aspirate (BMAC) for Angina ReductionCardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. · AnginaTerminatedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2011ActualNo phase registeredNCT01236469CryoValve® SG Aortic Human Heart Valve Combination StudyCryoLife, Inc. · Aortic Valve StenosisCompletedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2012ActualPhase 3NCT01458561Adjunctive Application of BioFoam Surgical Matrix in Liver SurgeryCryoLife, Inc. · Intraoperative BleedingTerminatedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2011ActualNo phase registeredNCT01386021Saphenous Vein Allografts for Coronary BypassCryoLife, Inc. · Coronary Artery DiseaseCompletedAORTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 26, 2018ActualNo phase registeredNCT03397251DARTS I: Feasibility, Safety, and Performance TrialAscyrus Medical LLC. · Acute DeBakey I Aortic DissectionCompletedAORTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 21, 2019ActualNo phase registeredNCT03035643DARTS I Feasibility StudyAscyrus Medical LLC. · Aortic DissectionCompletedAORTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2008ActualNo phase registeredNCT00890045Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency StudyMerit Medical Systems, Inc. · Renal Failure Chronic Requiring HemodialysisCompletedMMSILeadAORTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2018Sponsor estimateNo phase registeredNCT02164175Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving HemodialysisMerit Medical Systems, Inc. · End Stage Renal Failure on DialysisWithdrawnMMSILeadAORTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 6, 2017ActualNo phase registeredNCT02612220Effectiveness of BioFoam® Surgical Matrix to Improve Hemostasis During Liver ResectionTechnische Universität Dresden · HemorrhageCompletedAORTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2013ActualNo phase registeredNCT01343251HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving HemodialysisMerit Medical Systems, Inc. · End Stage Renal Disease (ESRD)CompletedMMSILeadAORTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 2 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner